SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-122059
Filing Date
2021-04-20
Accepted
2021-04-20 09:01:57
Documents
16
Period of Report
2021-04-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d141575d8k.htm   iXBRL 8-K 71977
2 EX-10.1 d141575dex101.htm EX-10.1 1302694
3 EX-99.1 d141575dex991.htm EX-99.1 13970
4 EX-99.2 d141575dex992.htm EX-99.2 273743
8 GRAPHIC g141575snap7.jpg GRAPHIC 3900
  Complete submission text file 0001193125-21-122059.txt   2138160

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA jazz-20210420.xsd EX-101.SCH 3075
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE jazz-20210420_lab.xml EX-101.LAB 18839
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jazz-20210420_pre.xml EX-101.PRE 11842
9 EXTRACTED XBRL INSTANCE DOCUMENT d141575d8k_htm.xml XML 3535
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 21836420
SIC: 2834 Pharmaceutical Preparations